Clinical Trial Update: Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients

View source ↗

Summary

Clinical trial investigating risk factors for coronary artery calcification and left ventricular hypertrophy in hemodialysis patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: University of Alberta | Conditions: End Stage Renal Disease | Status: TERMINATED